Literature DB >> 18084245

Aberrant fibrillin-1 expression in early emphysematous human lung: a proposed predisposition for emphysema.

Antoine A Robbesom1, Mieke M J F Koenders, Nicole C Smits, Theo Hafmans, Elly M M Versteeg, Johan Bulten, Jacques H Veerkamp, P N Richard Dekhuijzen, Toin H van Kuppevelt.   

Abstract

Parenchymal destruction, airspace enlargement, and loss of elasticity are hallmarks of pulmonary emphysema. Although the basic mechanism is unknown, there is a consensus that malfunctioning of the extracellular matrix is a major contributor to the pathogenesis of emphysema. In this study, we analyzed the expression of the elastic fiber protein fibrillin-1 in a large number (n=69) of human lung specimens with early-onset emphysema. Specimens were morphologically characterized by the Destructive Index, the Mean Linear Intercept, and the Panel Grading. We observed a strong correlation (P<0.001) of aberrant fibrillin-1 staining with the degree of destruction of lung parenchyma (r=0.71), airspace enlargement (r=0.47), and emphysema-related morphological abnormalities (r=0.69). There were no obvious correlations with age and smoking behavior. Staining for three other extracellular matrix components (type I collagen, type IV collagen, and laminin) was not affected. The aberrant fibrillin-1 staining observed in this study is similar to that observed in Marfan syndrome, a syndrome caused by mutations in the gene encoding fibrillin-1. Strikingly, emphysema is noticed in a number of Marfan patients. This, together with the notion that disruption of the fibrillin-1 gene in mice results in emphysematous lesions, makes fibrillin-1 a strong candidate to be involved in the etiology and pathogenesis of emphysema.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18084245     DOI: 10.1038/modpathol.3801004

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  17 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 2.  Tissue elasticity and the ageing elastic fibre.

Authors:  Michael J Sherratt
Journal:  Age (Dordr)       Date:  2009-12

3.  Enlarged Dural Sac in Idiopathic Bronchiectasis Implicates Heritable Connective Tissue Gene Variants.

Authors:  M Leigh Anne Daniels; Katherine R Birchard; Jared R Lowe; Michael V Patrone; Peadar G Noone; Michael R Knowles
Journal:  Ann Am Thorac Soc       Date:  2016-10

Review 4.  Drug-based therapies for vascular disease in Marfan syndrome: from mouse models to human patients.

Authors:  Jason R Cook; Harikiran Nistala; Francesco Ramirez
Journal:  Mt Sinai J Med       Date:  2010 Jul-Aug

Review 5.  Extracellular matrix in lung development, homeostasis and disease.

Authors:  Yong Zhou; Jeffrey C Horowitz; Alexandra Naba; Namasivayam Ambalavanan; Kamran Atabai; Jenna Balestrini; Peter B Bitterman; Richard A Corley; Bi-Sen Ding; Adam J Engler; Kirk C Hansen; James S Hagood; Farrah Kheradmand; Qing S Lin; Enid Neptune; Laura Niklason; Luis A Ortiz; William C Parks; Daniel J Tschumperlin; Eric S White; Harold A Chapman; Victor J Thannickal
Journal:  Matrix Biol       Date:  2018-03-08       Impact factor: 11.583

6.  A ferret model of COPD-related chronic bronchitis.

Authors:  S Vamsee Raju; Hyunki Kim; Stephen A Byzek; Li Ping Tang; John E Trombley; Patricia Jackson; Lawrence Rasmussen; J Michael Wells; Emily Falk Libby; Erik Dohm; Lindy Winter; Sharon L Samuel; Kurt R Zinn; J Edwin Blalock; Trenton R Schoeb; Mark T Dransfield; Steven M Rowe
Journal:  JCI Insight       Date:  2016-09-22

7.  Integrative pathway genomics of lung function and airflow obstruction.

Authors:  Sina A Gharib; Daan W Loth; María Soler Artigas; Timothy P Birkland; Jemma B Wilk; Louise V Wain; Jennifer A Brody; Ma'en Obeidat; Dana B Hancock; Wenbo Tang; Rajesh Rawal; H Marike Boezen; Medea Imboden; Jennifer E Huffman; Lies Lahousse; Alexessander C Alves; Ani Manichaikul; Jennie Hui; Alanna C Morrison; Adaikalavan Ramasamy; Albert Vernon Smith; Vilmundur Gudnason; Ida Surakka; Veronique Vitart; David M Evans; David P Strachan; Ian J Deary; Albert Hofman; Sven Gläser; James F Wilson; Kari E North; Jing Hua Zhao; Susan R Heckbert; Deborah L Jarvis; Nicole Probst-Hensch; Holger Schulz; R Graham Barr; Marjo-Riitta Jarvelin; George T O'Connor; Mika Kähönen; Patricia A Cassano; Pirro G Hysi; Josée Dupuis; Caroline Hayward; Bruce M Psaty; Ian P Hall; William C Parks; Martin D Tobin; Stephanie J London
Journal:  Hum Mol Genet       Date:  2015-09-22       Impact factor: 6.150

8.  Regional heterogeneity in murine lung fibroblasts from normal mice or mice exposed once to cigarette smoke.

Authors:  Olena Preobrazhenska; Joanne L Wright; Andrew Churg
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

9.  Cellular and molecular basis of Venous insufficiency.

Authors:  Elizabeth S Pocock; Tom Alsaigh; Rafi Mazor; Geert W Schmid-Schönbein
Journal:  Vasc Cell       Date:  2014-12-12

10.  A treatment with a protease inhibitor recombinant from the cattle tick (Rhipicephalus Boophilus microplus) ameliorates emphysema in mice.

Authors:  Juliana D Lourenço; Luana P Neves; Clarice R Olivo; Adriana Duran; Francine M Almeida; Petra M M Arantes; Carla M Prado; Edna Aparecida Leick; Aparecida S Tanaka; Mílton A Martins; Sergio D Sasaki; Fernanda D T Q S Lopes
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.